Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Treatment Patterns and Outcomes in Lenalidomide-Exposed Multiple Myeloma Patients in Real-World Settings: A Multi-Center Retrospective Study

Maria Eduarda Couto, Marina Borges, Maria José Bento, Rita Calisto, Marta Daniela Marques Magalhaes, Adil Ajmal, Nicolas Niklas, Kirill Dushkin, Finlay MacDougall, Andrea Wolf, Shabnam Shaid, Ivana von Metzler

Blood (2021) 138 (Supplement 1): 5012.

https://doi.org/10.1182/blood-2021-148724

Published: 2021

Journal Articles

Phase I/II Study of the Deacetylase Inhibitor Panobinostat As Maintenance Therapy after an Allogeneic Stem Cell Transplantation in Patients with High-Risk MDS or AML: The Panobest-Trial

Gesine Bug, MD, Andreas Burchert, MD, Eva-Maria Wagner, MD, Nicolaus Kroeger, MD, Zuzana Jedlickova, MD, Saskia Gueller, MD, Stephan Metzelder, MD, Andrea Wolf, Peter Bader, MD, Sabine Huenecke, PhD, Hubert Serve, Oliver G. Ottmann, MD

Blood (2015) 126 (23): 4344.

https://doi.org/10.1182/blood.V126.23.4344.4344

Published: 2015

Journal Articles

Favorable Outcome in a Large Cohort of Prospectively Treated Adult Patients with T-Lymphoblastic Lymphoma (T-LBL) Despite Slowly Evolving Complete Remission Assessed By Conventional Radiography

Nicola Gökbuget, MD, Andrea Wolf, Matthias Stelljes, MD, Andreas Hüttmann, MD, Eike C. Buss, Andreas Viardot, Kalina Brandt, MD, Maike de Wit, MD, Norbert Frickhofen, MD, Maxim Kebenko, MD, Mustafa Kondakci, MD, Doris Kraemer, MD, Stefan Schwartz, MD, Hubert Serve, MD, Karsten Spiekermann, MD, Reingard Stuhlmann, MD, Albrecht Reichle, Dieter Hoelzer, MD

Blood (2014) 124 (21): 370.

https://doi.org/10.1182/blood.V124.21.370.370

Published: 2014

Journal Articles

Post-Transplant Maintenance With The Deacetylase Inhibitor Panobinostat In Patients With High-Risk AML Or MDS: Results Of The Phase I Part Of The Panobest Trial

Gesine Bug, MD, PhD, Andreas Burchert, MD, Kroeger Nicolaus, MD, Sabine Huenecke, PhD, Ulrich Duenzinger, MD, Andrea Wolf, Peter Bader, Hubert Serve, MD, Oliver G. Ottmann, MD

Blood (2013) 122 (21): 3315.

https://doi.org/10.1182/blood.V122.21.3315.3315

Published: 2013

Journal Articles

Safety and Efficacy Of BEZ235, a Dual PI3-Kinase /mTOR Inhibitor, In Adult Patients With Relapsed Or Refractory Acute Leukemia: Results Of a Phase I Study

Lydia Wunderle, MD, Susanne Badura, Fabian Lang, MD, Andrea Wolf, Eberhard Schleyer, MD, Hubert Serve, MD, Nicola Goekbuget, MD, Heike Pfeifer, MD, Gesine Bug, MD, PhD, Oliver G. Ottmann, MD

Blood (2013) 122 (21): 2675.

https://doi.org/10.1182/blood.V122.21.2675.2675

Published: 2013

NARROW

Treatment Patterns and Outcomes in Lenalidomide-Exposed Multiple Myeloma Patients in Real-World Settings: A Multi-Center Retrospective Study

Phase I/II Study of the Deacetylase Inhibitor Panobinostat As Maintenance Therapy after an Allogeneic Stem Cell Transplantation in Patients with High-Risk MDS or AML: The Panobest-Trial

Favorable Outcome in a Large Cohort of Prospectively Treated Adult Patients with T-Lymphoblastic Lymphoma (T-LBL) Despite Slowly Evolving Complete Remission Assessed By Conventional Radiography

Post-Transplant Maintenance With The Deacetylase Inhibitor Panobinostat In Patients With High-Risk AML Or MDS: Results Of The Phase I Part Of The Panobest Trial

Safety and Efficacy Of BEZ235, a Dual PI3-Kinase /mTOR Inhibitor, In Adult Patients With Relapsed Or Refractory Acute Leukemia: Results Of a Phase I Study

Email alerts

ASH Publications

American Society of Hematology

Treatment Patterns and Outcomes in Lenalidomide-Exposed Multiple Myeloma Patients in Real-World Settings: A Multi-Center Retrospective Study

Phase I/II Study of the Deacetylase Inhibitor Panobinostat As Maintenance Therapy after an Allogeneic Stem Cell Transplantation in Patients with High-Risk MDS or AML: The Panobest-Trial

Favorable Outcome in a Large Cohort of Prospectively Treated Adult Patients with T-Lymphoblastic Lymphoma (T-LBL) Despite Slowly Evolving Complete Remission Assessed By Conventional Radiography

Post-Transplant Maintenance With The Deacetylase Inhibitor Panobinostat In Patients With High-Risk AML Or MDS: Results Of The Phase I Part Of The Panobest Trial

Safety and Efficacy Of BEZ235, a Dual PI3-Kinase /mTOR Inhibitor, In Adult Patients With Relapsed Or Refractory Acute Leukemia: Results Of a Phase I Study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only